139 related articles for article (PubMed ID: 35169798)
1. Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques.
Chandrashekar A; Yu J; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Anioke T; Barrett J; Chung B; Hachmann NP; Lifton M; Miller J; Powers O; Sciacca M; Sellers D; Siamatu M; Surve N; VanWyk H; Wan H; Wu C; Pessaint L; Valentin D; Van Ry A; Muench J; Boursiquot M; Cook A; Velasco J; Teow E; Boon ACM; Suthar MS; Jain N; Martinot AJ; Lewis MG; Andersen H; Barouch DH
bioRxiv; 2022 Feb; ():. PubMed ID: 35169798
[TBL] [Abstract][Full Text] [Related]
2. Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.
Chandrashekar A; Yu J; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Anioke T; Barrett J; Chung B; Hachmann NP; Lifton M; Miller J; Powers O; Sciacca M; Sellers D; Siamatu M; Surve N; VanWyk H; Wan H; Wu C; Pessaint L; Valentin D; Van Ry A; Muench J; Boursiquot M; Cook A; Velasco J; Teow E; Boon ACM; Suthar MS; Jain N; Martinot AJ; Lewis MG; Andersen H; Barouch DH
Cell; 2022 Apr; 185(9):1549-1555.e11. PubMed ID: 35427477
[TBL] [Abstract][Full Text] [Related]
3. Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
Yu J; Thomas PV; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Martinez EJ; Chen WH; Sciacca M; Hachmann NP; Lifton M; Miller J; Powers OC; Hall K; Wu C; Barrett J; Swafford I; Currier JR; King J; Corbitt C; Chang WC; Golub E; Rees PA; Peterson CE; Hajduczki A; Hussin E; Lange C; Gong H; Matyas GR; Rao M; Paquin-Proulx D; Gromowski GD; Lewis MG; Andersen H; Davis-Gardner M; Suthar MS; Michael NL; Bolton DL; Joyce MG; Modjarrad K; Barouch DH
Sci Adv; 2022 Nov; 8(47):eade4433. PubMed ID: 36417525
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques.
He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
bioRxiv; 2021 Jan; ():. PubMed ID: 33532782
[TBL] [Abstract][Full Text] [Related]
5. Durability of Heterologous and Homologous COVID-19 Vaccine Boosts.
Tan CS; Collier AY; Yu J; Liu J; Chandrashekar A; McMahan K; Jacob-Dolan C; He X; Roy V; Hauser BM; Munt JE; Mallory ML; Mattocks M; Powers JM; Meganck RM; Rowe M; Hemond R; Bondzie EA; Jaegle KH; Baric RS; Schmidt AG; Alter G; Le Gars M; Sadoff J; Barouch DH
JAMA Netw Open; 2022 Aug; 5(8):e2226335. PubMed ID: 35947380
[TBL] [Abstract][Full Text] [Related]
6. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques.
Liu J; Yu J; McMahan K; Jacob-Dolan C; He X; Giffin V; Wu C; Sciacca M; Powers O; Nampanya F; Miller J; Lifton M; Hope D; Hall K; Hachmann NP; Chung B; Anioke T; Li W; Muench J; Gamblin A; Boursiquot M; Cook A; Lewis MG; Andersen H; Barouch DH
Sci Immunol; 2022 Nov; 7(77):eabq7647. PubMed ID: 35943359
[TBL] [Abstract][Full Text] [Related]
7. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van Heerden M; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
Cell; 2021 Jun; 184(13):3467-3473.e11. PubMed ID: 34133941
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
Yu J; Tostanoski LH; Mercado NB; McMahan K; Liu J; Jacob-Dolan C; Chandrashekar A; Atyeo C; Martinez DR; Anioke T; Bondzie EA; Chang A; Gardner S; Giffin VM; Hope DL; Nampanya F; Nkolola J; Patel S; Sanborn O; Sellers D; Wan H; Hayes T; Bauer K; Pessaint L; Valentin D; Flinchbaugh Z; Brown R; Cook A; Bueno-Wilkerson D; Teow E; Andersen H; Lewis MG; Martinot AJ; Baric RS; Alter G; Wegmann F; Zahn R; Schuitemaker H; Barouch DH
Nature; 2021 Aug; 596(7872):423-427. PubMed ID: 34161961
[TBL] [Abstract][Full Text] [Related]
9. Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques.
Yu J; Thomas PV; Sciacca M; Wu C; Liu J; He X; Miller J; Hachmann NP; Surve N; McMahan K; Jacob-Dolan C; Powers O; Hall K; Barrett J; Hope D; Mazurek CR; Murdza T; Chang WC; Golub E; Rees PA; Peterson CE; Hajduczki A; Chen WH; Martinez EJ; Hussin E; Lange C; Gong H; Matyas GR; Rao M; Suthar M; Boursiquot M; Cook A; Pessaint L; Lewis MG; Andersen H; Bolton DL; Michael NL; Joyce MG; Modjarrad K; Barouch DH
Cell Rep Med; 2023 Apr; 4(4):101018. PubMed ID: 37023746
[TBL] [Abstract][Full Text] [Related]
10. Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.
Solforosi L; Costes LMM; Tolboom JTBM; McMahan K; Anioke T; Hope D; Murdza T; Sciacca M; Bouffard E; Barrett J; Wu C; Hachmann N; Miller J; Yu J; He X; Jacob-Dolan C; Huber SKR; Dekking L; Chamanza R; Choi Y; Boer KF; Barouch DH; Schuitemaker H; Zahn RC; Wegmann F
Nat Commun; 2023 Apr; 14(1):1944. PubMed ID: 37029141
[TBL] [Abstract][Full Text] [Related]
11. A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.
He X; Aid M; Chandrashekar A; Yu J; McMahan K; Wegmann F; Jacob-Dolan C; Maron JS; Atyeo C; Wan H; Sellers D; Liu J; Lifton M; Gardner S; Bondzie EA; Barrett J; Ahmad K; Anioke T; Yalley-Ogunro J; Muench J; Goode A; Andersen H; Lewis MG; Alter G; Schuitemaker H; Zahn R; Barouch DH
Sci Transl Med; 2022 Mar; 14(638):eabm4996. PubMed ID: 35191769
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
Hyun H; Jang AY; Park H; Heo JY; Seo YB; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ; Yoon SY; Seok JH; Kim J; Park MS; Song JY
Front Immunol; 2023; 14():1131229. PubMed ID: 36960070
[TBL] [Abstract][Full Text] [Related]
13. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Mercado NB; Zahn R; Wegmann F; Loos C; Chandrashekar A; Yu J; Liu J; Peter L; McMahan K; Tostanoski LH; He X; Martinez DR; Rutten L; Bos R; van Manen D; Vellinga J; Custers J; Langedijk JP; Kwaks T; Bakkers MJG; Zuijdgeest D; Rosendahl Huber SK; Atyeo C; Fischinger S; Burke JS; Feldman J; Hauser BM; Caradonna TM; Bondzie EA; Dagotto G; Gebre MS; Hoffman E; Jacob-Dolan C; Kirilova M; Li Z; Lin Z; Mahrokhian SH; Maxfield LF; Nampanya F; Nityanandam R; Nkolola JP; Patel S; Ventura JD; Verrington K; Wan H; Pessaint L; Van Ry A; Blade K; Strasbaugh A; Cabus M; Brown R; Cook A; Zouantchangadou S; Teow E; Andersen H; Lewis MG; Cai Y; Chen B; Schmidt AG; Reeves RK; Baric RS; Lauffenburger DA; Alter G; Stoffels P; Mammen M; Van Hoof J; Schuitemaker H; Barouch DH
Nature; 2020 Oct; 586(7830):583-588. PubMed ID: 32731257
[TBL] [Abstract][Full Text] [Related]
14. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
McMahan K; Wegmann F; Aid M; Sciacca M; Liu J; Hachmann NP; Miller J; Jacob-Dolan C; Powers O; Hope D; Wu C; Pereira J; Murdza T; Mazurek CR; Hoyt A; Boon ACM; Davis-Gardner M; Suthar MS; Martinot AJ; Boursiquot M; Cook A; Pessaint L; Lewis MG; Andersen H; Tolboom J; Serroyen J; Solforosi L; Costes LMM; Zahn RC; Barouch DH
Nature; 2024 Feb; 626(7998):385-391. PubMed ID: 38096903
[TBL] [Abstract][Full Text] [Related]
15. Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients.
GeurtsvanKessel CH; Geers D; Schmitz KS; Mykytyn AZ; Lamers MM; Bogers S; Scherbeijn S; Gommers L; Sablerolles RSG; Nieuwkoop NN; Rijsbergen LC; van Dijk LLA; de Wilde J; Alblas K; Breugem TI; Rijnders BJA; de Jager H; Weiskopf D; van der Kuy PHM; Sette A; Koopmans MPG; Grifoni A; Haagmans BL; de Vries RD
Sci Immunol; 2022 Mar; 7(69):eabo2202. PubMed ID: 35113647
[TBL] [Abstract][Full Text] [Related]
16. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
[TBL] [Abstract][Full Text] [Related]
17. Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations.
Jacobsen H; Strengert M; Maaß H; Ynga Durand MA; Katzmarzyk M; Kessel B; Harries M; Rand U; Abassi L; Kim Y; Lüddecke T; Metzdorf K; Hernandez P; Ortmann J; Heise JK; Castell S; Gornyk D; Glöckner S; Melhorn V; Kemmling Y; Lange B; Dulovic A; Marsall P; Häring J; Junker D; Schneiderhan-Marra N; Hoffmann M; Pöhlmann S; Krause G; Cicin-Sain L
Sci Rep; 2022 Nov; 12(1):19858. PubMed ID: 36400804
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Tan NH; Geers D; Sablerolles RSG; Rietdijk WJR; Goorhuis A; Postma DF; Visser LG; Bogers S; van Dijk LLA; Gommers L; van Leeuwen LPM; Boerma A; Nijhof SH; van Dort KA; Koopmans MPG; Dalm VASH; Lafeber M; Kootstra NA; Huckriede ALW; van Baarle D; Zaeck LM; GeurtsvanKessel CH; de Vries RD; van der Kuy PHM;
Lancet Infect Dis; 2023 Aug; 23(8):901-913. PubMed ID: 37088096
[TBL] [Abstract][Full Text] [Related]
19. In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant.
Heinen N; Marheinecke CS; Bessen C; Blazquez-Navarro A; Roch T; Stervbo U; Anft M; Plaza-Sirvent C; Busse S; Klöhn M; Schrader J; Vidal Blanco E; Urlaub D; Watzl C; Hoffmann M; Pöhlmann S; Tenbusch M; Steinmann E; Todt D; Hagenbeck C; Zimmer G; Schmidt WE; Quast DR; Babel N; Schmitz I; Pfänder S
Front Immunol; 2022; 13():1062210. PubMed ID: 36618413
[TBL] [Abstract][Full Text] [Related]
20. Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant.
Liu J; Chandrashekar A; Sellers D; Barrett J; Lifton M; McMahan K; Sciacca M; VanWyk H; Wu C; Yu J; Collier AY; Barouch DH
medRxiv; 2022 Jan; ():. PubMed ID: 35018387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
